The katheter assisted veneous sclerotherapy (KAVS) is a new method to treat varicose veins. It has been developed by Dr. Jens Brodersen at the medical UNiversity in Hannover, Germany. First treatment showed, that the KAVS method improves significantly the current venous sklerotherapy. The risks coorespond to the known risks of the current venous skleortherapy methods.

Further information is available at the KAVS Web-site: www.kavs-info.de

The KAVS catheter is a new double-lumen balloon-catheter for the venous sclerotherapy. It is particularly designed for the catheter assisted venous sclerotherapy

The KAVS Method in brief:

• Open the vein and put the catheter forward
• Inflate the balloon with NaCl and block the vein
• Inject the sclerosing agent
• Control the effect via ultrasound
• Aspirate the sclerosing agent after the effect
• Un-block the vein and remove the catheter

Keyword sclerosing foam: foam provides a larger surface by less liquid and is better seen via ultrasound.

The KAVS catheter is patented and CE-certified (CE 0483). Since March 2006 it is also cleared by the US Food and Drug Administration (FDA)

Part no.	Dimension
1107100	Ch. 7 (2,1 mm, 7F), length 100 cm
1104060	Ch. 4 (1,3 mm, 4F), length 60 cm